Cargando…

The TEAD Family and Its Oncogenic Role in Promoting Tumorigenesis

The TEAD family of transcription factors is necessary for developmental processes. The family members contain a TEA domain for the binding with DNA elements and a transactivation domain for the interaction with transcription coactivators. TEAD proteins are required for the participation of coactivat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yuhang, Huang, Tingting, Cheng, Alfred S. L., Yu, Jun, Kang, Wei, To, Ka Fai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4730377/ https://www.ncbi.nlm.nih.gov/pubmed/26805820 http://dx.doi.org/10.3390/ijms17010138

Ejemplares similares

The physiological role of Motin family and its dysregulation in tumorigenesis
por: Huang, Tingting, et al.
Publicado: (2018)

TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis
por: Zhou, Y, et al.
Publicado: (2017)

NOTCH receptors in gastric and other gastrointestinal cancers: oncogenes or tumor suppressors?
por: Huang, Tingting, et al.
Publicado: (2016)

The oncogenic role of Epstein–Barr virus‐encoded microRNAs in Epstein–Barr virus‐associated gastric carcinoma
por: Zhang, Jinglin, et al.
Publicado: (2017)

CK2-induced cooperation of HHEX with the YAP-TEAD4 complex promotes colorectal tumorigenesis
por: Guo, Yuegui, et al.
Publicado: (2022)

Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

Mechanotransduction and Cytoskeleton Remodeling Shaping YAP1 in Gastric Tumorigenesis
por: Zhang, Jinglin, et al.
Publicado: (2019)

TEAD4 as an Oncogene and a Mitochondrial Modulator
por: Hsu, Sheng-Chieh, et al.
Publicado: (2022)

The Interplay of LncRNA-H19 and Its Binding Partners in Physiological Process and Gastric Carcinogenesis
por: Zhang, Li, et al.
Publicado: (2017)

G-quadruplexes formation within the promoter of TEAD4 oncogene and their interaction with Vimentin
por: Cozzaglio, Marta, et al.
Publicado: (2022)

SRGAP1, a crucial target of miR-340 and miR-124, functions as a potential oncogene in gastric tumorigenesis
por: Huang, Tingting, et al.
Publicado: (2017)

miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis
por: Kang, Wei, et al.
Publicado: (2018)

IGF2BP3 functions as a potential oncogene and is a crucial target of miR-34a in gastric carcinogenesis
por: Zhou, Yuhang, et al.
Publicado: (2017)

The emerging role of Slit-Robo pathway in gastric and other gastro intestinal cancers
por: Huang, Tingting, et al.
Publicado: (2015)

Emerging roles of TEAD transcription factors and its coactivators in cancers
por: Pobbati, Ajaybabu V., et al.
Publicado: (2013)

VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle
por: Figeac, Nicolas, et al.
Publicado: (2019)

Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019)

PHF5A promotes colorectal cancerprogression by alternative splicing of TEAD2
por: Chang, Yue, et al.
Publicado: (2021)

FGF18, a prominent player in FGF signaling, promotes gastric tumorigenesis through autocrine manner and is negatively regulated by miR-590-5p
por: Zhang, Jinglin, et al.
Publicado: (2018)

YAP1 subgroup supratentorial ependymoma requires TEAD and nuclear factor I-mediated transcriptional programmes for tumorigenesis
por: Pajtler, Kristian W., et al.
Publicado: (2019)

ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling
por: Davis, Jason E., et al.
Publicado: (2016)

Targeting the Hippo Pathway and Cancer through the TEAD Family of Transcription Factors
por: Holden, Jeffrey K., et al.
Publicado: (2018)

Gatekeepers of pancreas: TEAD and YAP
por: Rodríguez-Seguí, Santiago A., et al.
Publicado: (2015)

JUND Promotes Tumorigenesis via Specifically Binding on Enhancers of Multiple Oncogenes in Cervical Cancer
por: Zhou, Jianlong, et al.
Publicado: (2023)

Stathmin1 Plays Oncogenic Role and Is a Target of MicroRNA-223 in Gastric Cancer
por: Kang, Wei, et al.
Publicado: (2012)

Oncogenic super-enhancer formation in tumorigenesis and its molecular mechanisms
por: Jia, Qunying, et al.
Publicado: (2020)

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis
por: DeNicola, Gina M., et al.
Publicado: (2011)

The role of lysine palmitoylation/myristoylation in the function of the TEAD transcription factors
por: Mesrouze, Yannick, et al.
Publicado: (2022)

Ubiquitin Specific Protease 29 Functions as an Oncogene Promoting Tumorigenesis in Colorectal Carcinoma
por: Chandrasekaran, Arun Pandian, et al.
Publicado: (2021)

Significance of TEAD Family in Diagnosis, Prognosis and Immune Response for Ovarian Serous Carcinoma
por: Ren, Xinxin, et al.
Publicado: (2021)

CREPT Disarms the Inhibitory Activity of HDAC1 on Oncogene Expression to Promote Tumorigenesis
por: Cao, Yajun, et al.
Publicado: (2022)

Crystal structure of TAZ-TEAD complex reveals a distinct interaction mode from that of YAP-TEAD complex
por: Kaan, Hung Yi Kristal, et al.
Publicado: (2017)

Multifaceted function of YAP/TEAD on chromatin:prospects of ‘A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer’
por: Chen, Lizhen, et al.
Publicado: (2019)

Oncogene-induced NAD(+) depletion in tumorigenesis
por: Tummala, Krishna S., et al.
Publicado: (2015)

TEAD4 is a master regulator of high-risk nasopharyngeal carcinoma
por: Wang, Ya-Qin, et al.
Publicado: (2023)

SUZ12 is a novel putative oncogene promoting tumorigenesis in head and neck squamous cell carcinoma
por: Wu, Yaping, et al.
Publicado: (2018)

Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation
por: Ren, Xinxin, et al.
Publicado: (2022)

Structural and Functional Overview of TEAD4 in Cancer Biology
por: Chen, Mu, et al.
Publicado: (2020)

An allosteric pan-TEAD inhibitor blocks oncogenic YAP/TAZ signaling and overcomes KRAS G12C inhibitor resistance
por: Hagenbeek, Thijs J., et al.
Publicado: (2023)

Pharmacological blockade of TEAD–YAP reveals its therapeutic limitation in cancer cells
por: Sun, Yang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_is64n8b9hb3ihjjqf7ailikle7